Our other studies indicate that the inhibition of the MMP-2 expression by anti-cancer agent isorhapontigenin (ISO) significantly attenuated both BC invasion in vitro and highly invasive BC formation in vivo [27]. The gene discussed is MMP2; the disease is breast cancer.